Take a nice, deep breath. Now imagine your lungs: Myriad
Read moreLung model proves viability of spectroscopy technique
Home »
Lung drug hope for heart failure patients
An early phase trial of a drug currently used to
Read moreWhat drives severe lung inflammation in COVID-19?
A main feature of COVID-19 is lung inflammation and respiratory
Read moreIs elevated level of lung protein an early predictor for COPD?
Airway mucus consists of various proteins such as long mucins
Read moreDelaying lung cancer surgery associated with higher risk of recurrence, death
Swiftness is essential when treating lung cancer, the second most
Read moreCannabinoids May Pose Death Risk for Older Patients With COPD
Older adults with chronic obstructive pulmonary disease who began using
Read moreTexas schools, stores divided on masks as mandate ends
DALLAS — The end of Texas’ mask mandate is giving
Read moreLong-term exposure to low levels of air pollution increases risk of heart and lung disease
Exposure to what is considered low levels of air pollution
Read morePromising clinical data for fenofibrate’s ability to prevent lung damage in COVID-19 patients
In what has the potential to significantly change how Corona
Read moreMerck Presents Three-Year Survival Data for Keytruda (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With Keytruda in Advanced Non‑Small Cell Lung Cancer
KENILWORTH, N.J.–(BUSINESS WIRE) October 16, 2020 — Merck (NYSE: MRK),
Read more